First-line, single-agent Herceptin® (trastuzumab) in metastatic breast cancer
Titel:
First-line, single-agent Herceptin® (trastuzumab) in metastatic breast cancer
Auteur:
Vogel, C. Cobleigh, M.A. Tripathy, D. Gutheil, J.C. Harris, L.N. Fehrenbacher, L. Slamon, D.J. Murphy, M. Novotny, W.F. Burchmore, M. Shak, S. Stewart, S.J.